LEADER 04497nam  2200733 a 450 
001 9910971208903321
005 20251017110110.0
010   $a9786612081293
010   $a9780309175654
010   $a0309175658
010   $a9781282081291
010   $a1282081292
010   $a9780309522519
010   $a030952251X
010   $a9780585024516
010   $a0585024510
035   $a(CKB)110986584751770
035   $a(EBL)3375762
035   $a(SSID)ssj0000130026
035   $a(PQKBManifestationID)11139128
035   $a(PQKBTitleCode)TC0000130026
035   $a(PQKBWorkID)10080263
035   $a(PQKB)11656575
035   $a(MiAaPQ)EBC3375762
035   $a(Au-PeEL)EBL3375762
035   $a(CaPaEBR)ebr10041183
035   $a(OCoLC)923258673
035   $a(Perlego)4737242
035   $a(DNLM)998114463406676
035   $a(DNLM)811446
035   $a(BIP)47112323
035   $a(EXLCZ)99110986584751770
100   $a19960610d1996      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aContraceptive research and development $elooking to the future /$fPolly F. Harrison and Allan Rosenfield, editors ; Committee on Contraceptive Research and Development, Division of Health Sciences Policy, Institute of Medicine
205   $a1st ed.
210   $aWashington, D.C. $cNational Academy Press$d1996
215   $a1 online resource (536 pages) $cillustrations
300   $aBased on two workshops held in 1994-1995.
311 0 $a9780309054423 
311 0 $a0309054427 
320   $aIncludes bibliographical references and index.
327   $a""Front Matter""; ""Acknowledgments""; ""Contents""; ""Summary""; ""1 Introduction""; ""2 The Need and Demand for New Contraceptive Methods""; ""3 Contraceptive Technology and the State of the Science: Current and Near-future Methods""; ""4 Contraceptive Technology and the State of the Science: New Horizons""; ""5 The Market for New Contraceptives: Translating Unmet Need into Market Demand""; ""6 The Translators: Sectoral Roles in Contraceptive Research and Development""; ""7 Issues of Law, Regulation, Information, and the Environment for Contraceptive Research and Development""
327   $a""8 Recommendations""""A Female Methods""; ""B Male Methods""; ""C Immunocontraceptive Approaches""; ""D Part 1: Barrier Methods""; ""E Agendas and Participants in Committee Workshops""; ""F Committee Biographies""; ""Glossary""; ""Index""
330   $aThe "contraceptive revolution" of the 1960s and 1970s introduced totally new contraceptive options and launched an era of research and product development. Yet by the late 1980s, conditions had changed and improvements in contraceptive products, while very important in relation to improved oral contraceptives, IUDs, implants, and injectables, had become primarily incremental. Is it time for a second contraceptive revolution and how might it happen? Contraceptive Research and Development explores the frontiers of science where the contraceptives of the future are likely to be found and lays out criteria for deciding where to make the next R&D investments. The book comprehensively examines today's contraceptive needs, identifies "niches" in those needs that seem most readily translatable into market terms, and scrutinizes issues that shape the market: method side effects and contraceptive failure, the challenge of HIV/AIDS and other sexually transmitted diseases, and the implications of the "women's agenda." Contraceptive Research and Development analyzes the response of the pharmaceutical industry to current dynamics in regulation, liability, public opinion, and the economics of the health sector and offers an integrated set of recommendations for public- and private-sector action to meet a whole new generation of demand.
606   $aContraception$xResearch$vCongresses
606   $aContraception$xForecasting$vCongresses
615  0$aContraception$xResearch
615  0$aContraception$xForecasting
676   $a613.9/4
701   $aHarrison$b Polly F$01803611
701   $aRosenfield$b Allan$01811846
712 02$aInstitute of Medicine.$bCommittee on Contraceptive Research and Development.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910971208903321
996   $aContraceptive research and development$94363965
997   $aUNINA